Drug Shortage Report for MYLAN-TADALAFIL
| Report ID | 18688 |
| Drug Identification Number | 02410621 |
| Brand name | MYLAN-TADALAFIL |
| Common or Proper name | TADALAFIL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28BL |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-09-10 |
| Actual start date | 2018-09-10 |
| Estimated end date | 2018-12-14 |
| Actual end date | 2018-12-18 |
| Shortage status | Resolved |
| Updated date | 2018-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.